Geode Capital Management, LLC Mirum Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

$1.12 Trillion
Q2 2024

A detailed history of Geode Capital Management, LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 907,180 shares of MIRM stock, worth $36.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

907,180

Previous 697,139 30.13%

Holding current value

$36.4 Million

Previous $17.5 Million 77.11%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$23.57 - $34.85 $4.95 Million - $7.32 Million	210,041 Added 30.13%	907,180 $31 Million
Q1 2024 May 13, 2024	BUY	$24.92 - $30.02 $397,698 - $479,089	15,959 Added 2.34%	697,139 $17.5 Million
Q4 2023 Feb 13, 2024	BUY	$27.14 - $34.93 $2.88 Million - $3.71 Million	106,100 Added 18.45%	681,180 $20.1 Million
Q3 2023 Nov 13, 2023	BUY	$24.63 - $32.85 $1.22 Million - $1.63 Million	49,518 Added 9.42%	575,080 $18.2 Million
Q2 2023 Aug 11, 2023	BUY	$23.51 - $30.09 $2.52 Million - $3.23 Million	107,348 Added 25.67%	525,562 $13.6 Million
Q1 2023 May 15, 2023	BUY	$19.19 - $24.1 $355,629 - $446,621	18,532 Added 4.64%	418,214 $10 Million
Q4 2022 Feb 13, 2023	BUY	$17.59 - $23.83 $354,966 - $480,889	20,180 Added 5.32%	399,682 $7.79 Million
Q3 2022 Nov 14, 2022	BUY	$19.98 - $29.44 $1.97 Million - $2.9 Million	98,642 Added 35.12%	379,502 $7.97 Million
Q2 2022 Aug 12, 2022	BUY	$18.42 - $27.5 $1.56 Million - $2.32 Million	84,422 Added 42.98%	280,860 $5.47 Million
Q1 2022 May 13, 2022	BUY	$15.5 - $23.93 $364,947 - $563,431	23,545 Added 13.62%	196,438 $4.33 Million
Q4 2021 Feb 11, 2022	SELL	$13.05 - $19.35 $49,329 - $73,143	-3,780 Reduced 2.14%	172,893 $2.76 Million
Q3 2021 Nov 12, 2021	BUY	$13.95 - $20.18 $33,507 - $48,472	2,402 Added 1.38%	176,673 $3.52 Million
Q2 2021 Aug 13, 2021	BUY	$15.84 - $20.6 $29,161 - $37,924	1,841 Added 1.07%	174,271 $3.01 Million
Q1 2021 May 12, 2021	BUY	$16.29 - $21.92 $980,951 - $1.32 Million	60,218 Added 53.66%	172,430 $3.42 Million
Q4 2020 Feb 12, 2021	BUY	$15.75 - $25.45 $35,988 - $58,153	2,285 Added 2.08%	112,212 $1.96 Million
Q3 2020 Nov 13, 2020	BUY	$18.4 - $26.59 $99,120 - $143,240	5,387 Added 5.15%	109,927 $2.12 Million
Q2 2020 Aug 13, 2020	BUY	$11.51 - $20.97 $128,704 - $234,486	11,182 Added 11.98%	104,540 $2.03 Million
Q1 2020 May 14, 2020	BUY	$9.38 - $23.79 $326,330 - $827,654	34,790 Added 59.4%	93,358 $1.31 Million
Q4 2019 Feb 13, 2020	BUY	$6.84 - $25.9 $256,568 - $971,509	37,510 Added 178.13%	58,568 $1.44 Million
Q3 2019 Nov 12, 2019	BUY	$9.16 - $14.77 $192,891 - $311,026	21,058 New	21,058 $211,000

Others Institutions Holding MIRM

# of Institutions

172

Shares Held

54.2M

Call Options Held

96.1K

Put Options Held

54.8K

View Full List

About Mirum Pharmaceuticals, Inc.

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.47B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

More about MIRM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Mirum Pharmaceuticals, Inc. Transaction History